Danaher’s Cytiva Collaborates with CorrectSequence on Gene Therapy LNP Delivery System
US-based science and tech services giant Danaher Corporation (NYSE: DHR) announced an ongoing collaboration between...
CorrectSequence Therapeutics
CorrectSequence Therapeutics’ tBE Tech Wins USPTO Patent for Gene Editing
Shanghai-based gene editing firm CorrectSequence Therapeutics announced it has received a patent from the United...